APA

Han X., Raun S. H., Carlsson M., Sjøberg K. A., Henriquez-Olguín C., Ali M., Lundsgaard A., Fritzen A. M., Møller L. L. V., Li Z., Li J., Jensen T. E., Kiens B. & Sylow L. (20200427). Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. : Metabolism: clinical and experimental.

Chicago

Han Xiuqing, Raun Steffen H, Carlsson Michala, Sjøberg Kim A, Henriquez-Olguín Carlos, Ali Mona, Lundsgaard Anne-Marie, Fritzen Andreas M, Møller Lisbeth L V, Li Zhen, Li Jinwen, Jensen Thomas E, Kiens Bente and Sylow Lykke. 20200427. Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. : Metabolism: clinical and experimental.

Harvard

Han X., Raun S. H., Carlsson M., Sjøberg K. A., Henriquez-Olguín C., Ali M., Lundsgaard A., Fritzen A. M., Møller L. L. V., Li Z., Li J., Jensen T. E., Kiens B. and Sylow L. (20200427). Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. : Metabolism: clinical and experimental.

MLA

Han Xiuqing, Raun Steffen H, Carlsson Michala, Sjøberg Kim A, Henriquez-Olguín Carlos, Ali Mona, Lundsgaard Anne-Marie, Fritzen Andreas M, Møller Lisbeth L V, Li Zhen, Li Jinwen, Jensen Thomas E, Kiens Bente and Sylow Lykke. Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. : Metabolism: clinical and experimental. 20200427.